Atlas Trials

Olanzapine for Chemotherapy-induced Nausea and Vomiting Prophylaxis

Clinical trial NCT04232423 · COMPLETED

Trial details

NCT number
NCT04232423
Sponsor
Department of Medical Services Ministry of Public Health of Thailand
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Complete Response Rate to Chemotherapy-induced Nausea and Vomiting Prophylaxis
Start date
2020-03-01
Primary completion
2021-06-30
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.